PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-18.00%
Negative net income growth while BB stands at 600.00%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
-6.65%
Both reduce yoy D&A, with BB at -24.67%. Martin Whitman would suspect a lull in expansions or intangible additions for both.
-287.17%
Negative yoy deferred tax while BB stands at 508.00%. Joel Greenblatt would consider near-term tax obligations but a possible advantage if competitor's deferrals become a burden later.
0.33%
Less SBC growth vs. BB's 9.52%, indicating lower equity issuance. David Dodd would confirm the firm still retains key staff.
-19.61%
Both reduce yoy usage, with BB at -199.52%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-358.60%
Both yoy AR lines negative, with BB at -995.00%. Martin Whitman would suspect an overall sector lean approach or softer demand.
138.72%
Some inventory rise while BB is negative at -144.51%. John Neff would see competitor possibly benefiting from leaner stock if demand remains.
825.37%
AP growth of 825.37% while BB is zero at 0.00%. Bruce Berkowitz would see a moderate difference that might matter for short-term liquidity if expansions are large.
34.11%
Growth of 34.11% while BB is zero at 0.00%. Bruce Berkowitz would see a difference in minor WC usage that might affect short-term cash flow if large.
5.75%
Lower 'other non-cash' growth vs. BB's 120.00%, indicating steadier reported figures. David Dodd would confirm no missed necessary write-downs or gains.
-38.93%
Both yoy CFO lines are negative, with BB at -78.08%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-92.90%
Both yoy lines negative, with BB at -1.57%. Martin Whitman would suspect a cyclical or broad capital spending slowdown in the niche.
81.48%
Some acquisitions while BB is negative at -80.69%. John Neff sees competitor possibly pausing M&A or divesting while the firm invests in new deals.
-48.81%
Both yoy lines negative, with BB at -52.61%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
108.44%
Proceeds from sales/maturities above 1.5x BB's 53.36%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
-85.08%
Both yoy lines negative, with BB at -106.87%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
23.77%
We have mild expansions while BB is negative at -11.87%. John Neff sees competitor possibly divesting or pausing expansions more aggressively.
No Data
No Data available this quarter, please select a different quarter.
-18.23%
Negative yoy issuance while BB is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
-1.36%
We cut yoy buybacks while BB is 100.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.